Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 14, 2022 03:19 ET | Source: LumiraDx Inc

LumiraDx Announces New Investment for Ongoing Development of its Point of Care Molecular Tuberculosis Test

LONDON, Dec. 14, 2022 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: LMDX), a next-generation point of care diagnostics company, today announced it has received $14.2M in grants from the Bill &...
December 08, 2022 03:01 ET | Source: LumiraDx Inc

Point of Care (POC) Survey Reveals Majority of U.K. Clinicians Endorse Climate Benefits of POC Through Reduction of Carbon Emissions and Anticipate Future Growth of POC Testing to Come from Community Settings

LONDON, Dec. 08, 2022 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: LMDX), a next-generation point of care diagnostics company, today announced findings from its first annual U.K. survey, “Point of...
December 08, 2022 03:01 ET | Source: LumiraDx Inc

Latest Clinicians’ U.S. Survey Identifies Point of Care Testing (POCT) as a Way to Address Healthcare Bandwidth Pressures and Anticipates Future Growth of POCT in Community Testing Centers

WALTHAM, Mass., Dec. 08, 2022 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: LMDX), a next-generation point of care diagnostics company, today announced findings from its second annual “Point of Care...
November 14, 2022 02:58 ET | Source: LumiraDx Inc

LumiraDx Continues Commercial Expansion of its Rapid Microfluidic Immunoassay HbA1c Test

Early customers include GP offices and other community-based healthcare settingsLatest figures, released as part of World Diabetes Day, reveal that 1 in 10 adults are now living with diabetes and...
November 14, 2022 02:58 ET | Source: LumiraDx Inc

Mit HbA1c-Test erweitert LumiraDx erneut sein Mikrofluidik-Point-of-Care-Diagnostik-Portfolio

Zu den ersten Kunden gehören Allgemeinarztpraxen und andere patientennahe GesundheitseinrichtungenJüngste Zahlen, die im Rahmen des Weltdiabetestages veröffentlicht wurden, zeigen, dass inzwischen 1...
November 09, 2022 07:00 ET | Source: LumiraDx Inc

LumiraDx Reports Third Quarter 2022 Results

LONDON, Nov. 09, 2022 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: LMDX), a next-generation point of care (POC) diagnostics company, today announced operational and financial results for the third...
November 02, 2022 07:23 ET | Source: LumiraDx Inc

LumiraDx to Announce Third Quarter Financial Results and Host Quarterly Conference Call on November 9

LONDON, Nov. 02, 2022 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: LMDX), a next-generation point of care (POC) diagnostics company, announced it will release its third quarter financial results...
October 12, 2022 04:00 ET | Source: LumiraDx Inc

LumiraDx named by Frost & Sullivan as the 2022 Europe Technology Innovation Leader in the Microfluidics Point of Care Diagnostics Industry

LONDON, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Today, LumiraDx (Nasdaq: LMDX), a next-generation point of care diagnostics company, announced it has been named by Frost & Sullivan as the 2022 Europe...
September 22, 2022 04:12 ET | Source: LumiraDx Inc

LumiraDx Partners with British In Vitro Diagnostics Association to Report on the Role of Rapid Diagnostics in Tackling Antimicrobial Resistance

LONDON, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Today, LumiraDx Limited (Nasdaq: LMDX) a next-generation point of care diagnostics company, in partnership the British In Vitro Diagnostics Association,...
August 18, 2022 07:00 ET | Source: LumiraDx Inc

LumiraDx Reports Second Quarter 2022 Results

LONDON, Aug. 18, 2022 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: LMDX), a next-generation point of care (POC) diagnostics company, today announced operational and financial results for the second...